Proteomics-based characterization of hemagglutinins in different strains of influenza virus

Proteomics - Clinical Applications

Volumn 3, Issue 8, 2009, Pages 979-988

  Getie Kebtie, Melkamu ^a   Chen, David ^a   Eichelberger, Maryna ^a   Alterman, Michail ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Antigenic drift; Hemagglutinin; Influenza; Unique peptides; Vaccine

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; SIALIDASE; TRIPLE VACCINE;

ACCURACY; ARTICLE; COMPUTER MODEL; DRUG FORMULATION; FEASIBILITY STUDY; IMMUNITY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MASS SPECTROMETRY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEOMICS; VIRUS DETECTION; VIRUS STRAIN;

CERCOPITHECINE HERPESVIRUS 1; ORTHOMYXOVIRIDAE; TIPULA IRIDESCENT VIRUS;

EID: 70350238279     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800219     Document Type: Article

References (23)

1. Girard, M. P., Cherian, T., Pervikov, Y., Kieny, M. P., A review of vaccine research and development: human acute respiratory infections. Vaccine 2005, 23, 5708-5724.
2. Cox, N. J., Subbarao, K., Influenza. Lancet 1999, 354, 1277-1282.
3. Lipatov, A. S., Govorkova, E. A., Webby, R. J., Ozaki, H. et al., Influenza: emergence and control. J. Virol. 2004, 78, 8951-8959.
4. Kitler, M. E., Gavinio, P., Lavanchy, D., Influenza and the work of the World Health Organization. Vaccine 2002, 20, S5-S14.
5. Schild, G. C., Wood, J. M., Newman, R. W., A single-radialimmunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines. Bull. World Health Organ. 1975, 52, 223-231.
6. Wood, J. M., Mumford, J., Schild, G. C., Webster, R. G., Nicholson, K. G., Single-radial-immunodiffusion potency tests of inactivated influenza vaccines for use in man and animals. Dev. Biol. Stand. 1986, 64, 169-177.
7. Williams, M. S., Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines. Vet. Microbiol. 1993, 37, 253-262.
8. Tree, J.A., Richardson, C., Fooks, A. R., Clegg, J. C., Looby, D., Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 2001, 19, 3444-3450.
9. Palache, A. M., Brands, R., van Scharrenburg, G. J., Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs. J. Infect. Dis. 1997, 176, S20-S23.
10. Kessler, N., Thomas-Roche, G., Gerentes, L., Aymard, M., Suitability of MDCK cells grown in a serum-free medium for influenza virus production. Dev. Biol. Stand. 1999, 98, 13-21; discussion 73-14.
11. Merten, O. W., Hannoun, C., Manuguerra, J. C., Ventre, F., Petres, S., Production of influenza virus in cell cultures for vaccine preparation. Adv. Exp. Med. Biol. 1996, 397, 141-151.
12. Treanor, J. J., Schiff, G. M., Hayden, F. G., Brady, R. C. et al., Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA 2007, 297, 1577-1582.
13. Cox, M. M., Progress on baculovirus-derived influenza vaccines. Curr. Opin. Mol. Ther. 2008, 10, 56-61.
14. Johansson, B. E., Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine 1999, 17, 2073-2080.
15. Garcia-Canas, V., Lorbetskie, B., Girard, M., Rapid and selective characterization of influenza virus constituents in monovalent and multivalent preparations using nonporous reversed-phase high performance liquid chromatography columns. J. Chromatogr. 2006, 1123, 225-232.
16. Kapteyn, J. C., Saidi, M. D., Dijkstra, R., Kars, C. et al., Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RPHPLC method. Vaccine 2006, 24, 3137-3144.
17. Williams, T. L., Luna, L., Guo, Z., Cox, N. J. et al., Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. Vaccine 2008, 26, 2510-2520.
18. Getie-Kebtie, M., Franke, P., Aksamit, R., Alterman, M. A., Experimental evaluation of protein identification by an LC/MALDI/On-target digestion approach. J. Proteome Res. 2008, 7, 3697-3707.
19. Laver, W. G., Valentine, R. C., Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus. Virology 1969, 38, 105-119.
20. Bush, R. M., Bender, C. A., Subbarao, K., Cox, N. J., Fitch, W. M., Predicting the evolution of human influenza A. Science 1999, 286, 1921-1925.
21. Baez, M., Palese, P., Kilbourne, E. D., Gene composition of high-yielding influenza vaccine strains obtained by recombination. J. Infect. Dis. 1980, 141, 362-365.
22. Kiselar, J. G., Downard, K. M., Antigenic surveillance of the influenza virus by mass spectrometry. Biochemistry 1999, 38, 14185-14191.
23. Morrissey, B., Downard, K. M., A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry. Proteomics 2006, 6, 2034-2041.